The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Placing and Subscription

5 Jun 2020 07:00

RNS Number : 0544P
Bidstack Group PLC
05 June 2020
 

NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE MARKETABUSE REGULATION (EU NO. 596/2014).

5 June 2020

Bidstack Group PLC

("Bidstack" or the "Company")

Results of Placing and Subscription

Bidstack is pleased to announce the results of the placing (the "Placing") and the subscription (the "Subscription") announced on 4 June 2020.

The Placing was significantly over-subscribed and applicants have been scaled back. A total of 137,500,000 new ordinary shares of 0.5 pence each in the capital of the Company (the "Placing Shares") were placed by Stifel with institutional and other investors at a price of 4 pence per Placing Share (the "Placing Price"), raising gross proceeds of a £5.5 million.

In addition certain directors of the Company and others have subscribed for a total of 5,000,000 new ordinary shares of 0.5 pence each in the capital of the Company (the "Subscription Shares") at the Placing Price, raising gross proceeds of £200,000.

The Placing Shares and Subscription Shares being issued represent, in aggregate, circa 58.19 per cent. of Bidstack's issued ordinary share capital immediately prior to the Placing.

The Placing Shares and the Subscription Shares will, when issued, be subject to the Company's articles of association. They will be credited as fully paid and will rank pari passu in all respects with the existing ordinary shares in issue in the capital of the Company, including the right to receive all future dividends and distributions declared, made or paid on or in respect of such ordinary shares by reference to a record date falling after their date of issue.

Application has been made for the Placing Shares and the Subscription Shares to be admitted to trading on AIM ("Admission"). Subject to Admission becoming effective, it is expected that settlement of subscriptions in respect of the Placing Shares and the Subscription Shares and that trading in the Placing Shares and the Subscription Shares will commence at 8.00 a.m. on Wednesday 10 June 2020.

The Placing and Subscription are conditional upon, inter alia, Admission becoming effective not later than 8.00 a.m. (London time) on Wednesday 10 June 2020 (or such later time and/or date, being not later than 8.00 a.m. (London time) on 30 June 2020, as Stifel may agree with the Company) and the Placing Agreement not being terminated in accordance with its terms before that time.

As part of the Subscription Donald Stewart, Chairman of Bidstack, has subscribed for 625,000 Subscription Shares, John McIntosh, Finance Director, has subscribed for 750,000 Subscription Shares, Mike Hayes, non-Executive Director, has subscribed for 500,000 Subscription Shares and Derek Wise, non-Executive Director, has subscribed for 250,000 Subscription Shares. Following the Placing and Subscription the holdings of the Directors will be as follows:

 

Director

Existing number of Ordinary Shares

Number of Subscription Shares

Total number of Ordinary Shares following the Subscription

Proportion of the Enlarged Share Capital (%)

Donald Stewart

1,149,773

625,000

1,774,734

0.46%

James Draper

39,760,562

-

39,760,562

10.26%

Francesco Petruzzelli

5,750,000

-

5,750,000

1.48%

John McIntosh

200,000

750,000

950,000

0.25%

Mike Hayes

-

500,000

500,000

0.13%

Derek Wise

-

250,000

250,000

0.06%

Total:

46,860,335

2,125,000

48,985,296

12.65%

 

Stifel acted as sole broker and bookrunner in respect of the Placing.

Total Voting Rights

Following Admission becoming effective, the total number of voting rights in the Company will be 387,373,646. No ordinary shares of the Company are held in treasury. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Capitalised terms used but not defined in this announcement have the same meanings as set out in the placing announcement of the Company released at 4:55 p.m. (BST) on 4 June 2020.

Contacts

Bidstack Group PLC

James Draper, CEO

 

via Buchanan

SPARK Advisory Partners Limited (Nomad)

Mark Brady / Neil Baldwin / James Keeshan

 

+44 (0) 203 368 3550

Stifel Nicholas Europe Limited (Broker)

Fred Walsh

 

+44 (0) 20 7710 7600

Buchanan Communications Limited

Chris Lane / Stephanie Watson / Kim van Beeck

bidstack@buchanan.uk.com

 

+44 (0) 20 7466 5000

IMPORTANT NOTICE

Neither this Announcement, nor any copy of it, may be taken or transmitted, published or distributed, directly or indirectly, in or into the United States, Australia, Canada, Japan, or the Republic of South Africa or to any persons in any of those jurisdictions or any other jurisdiction where to do so would constitute a violation of the relevant securities laws of such jurisdiction. This Announcement is for information purposes only and does not constitute an offer to sell or issue, or the solicitation of an offer to buy, acquire or subscribe for any shares in the capital of the Company in the United States, Australia, Canada, Japan or the Republic of South Africa or any other state or jurisdiction in which such offer or solicitation is not authorised or to any person to whom it is unlawful to make such offer or solicitation. Any failure to comply with these restrictions may constitute a violation of securities laws of such jurisdictions.

The Placing Shares and the Subscription Shares have not been, and will not be, registered under the US Securities Act of 1933, as amended (the "US Securities Act"), or under any securities laws of any state or other jurisdiction of the United States and may not be offered, sold, resold, transferred or delivered, directly or indirectly, in or into the United States except pursuant to an applicable exemption from the registration requirements of the US Securities Act and in compliance with the securities laws of any state or other jurisdiction of the United States. There is no intention to register any portion of the Placing or the Subscription in the United States or to conduct any public offering of securities in the United States or elsewhere.

Notice to all investors

Stifel Nicolaus Europe Limited ("Stifel") is authorised and regulated in the United Kingdom by the FCA. Stifel is acting exclusively as sole broker and bookrunner to the Company in connection with the Placing and will not regard any other person (whether or not a recipient of this Announcement) as a client in relation to the Placing and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients or for providing advice in relation to the Placing or any transaction, matter or arrangement described in this announcement.

Apart from the responsibilities and liabilities, if any, which may be imposed upon Stifel by the Financial Services and Markets Act 2000, as amended ("FSMA") or the regulatory regime established thereunder, neither Stifel nor any of its affiliates, directors, officers, employees, agents or advisers accepts any responsibility whatsoever, and no representation or warranty, express or implied, is made or purported to be made by any of them, or on their behalf, for or in respect of the contents of this Announcement, including its accuracy, completeness, verification or sufficiency, or concerning any other document or statement made or purported to be made by it, or on its behalf, in connection with the Company, the Placing Shares, the Placing and the Subscription, and nothing in this announcement is, or shall be relied upon as, a warranty or representation in this respect, whether as to the past or future. Each of Stifel and its affiliates, directors, officers, employees, agents and advisers disclaim, to the fullest extent permitted by law, all and any liability whether arising in tort, contract or otherwise which they might otherwise be found to have in respect of this announcement or any such statement.

No person has been authorised to give any information or to make any representations other than those contained in this Announcement and, if given or made, such information or representations must not be relied on as having been authorised by the Company or Stifel. Subject to the AIM Rules, the Prospectus Regulation Rules and the Disclosure Guidance and Transparency Rules of the FCA, the issue of this Announcement shall not, in any circumstances, create any implication that there has been no change in the affairs of the Company since the date of this Announcement or that the information in it is correct as at any subsequent date.

Information to Distributors

Solely for the purposes of Article 9(8) of Commission Delegated Directive 2017/593 (the "Delegated Directive") regarding the responsibilities of manufacturers under the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended ("MiFID II"); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures (together, the "MiFID II Product Governance Requirements"), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any "manufacturer" (for the purposes of the MiFID II Product Governance Requirements) may otherwise have with respect thereto, the Placing Shares have been subject to a product approval process, which has determined that such Placing Shares are: (i) compatible with the target market for the Placing of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all eligible distribution channels for dissemination of the Placing Shares, each as set out in this Announcement, as are permitted by MiFID II (the "Target Market Assessment").

Notwithstanding the Target Market Assessment, distributors should note that: the price of the Placing Shares may decline and investors could lose all or part of their investment; the Placing Shares offer no guaranteed income and no capital protection; and an investment in the Placing Shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Placing. Furthermore, it is noted that, notwithstanding the Target Market Assessment, the Joint Bookrunners will only procure investors who meet the criteria of professional clients and eligible counterparties.

For the avoidance of doubt, the Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes of MiFID II; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to the Placing Shares.

Each distributor is responsible for undertaking its own target market assessment in respect of the Placing Shares and determining appropriate distribution channels.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROIFFFVVRFISIII
Date   Source Headline
19th Feb 20187:00 amRNSUpdate
27th Nov 20171:29 pmRNSTR-1: notification of major holdings
23rd Nov 20177:50 amRNSHolding(s) in Company
21st Nov 20178:13 amRNSHolding(s) in Company
17th Nov 20174:39 pmRNSTR-1: notification of major holdings
17th Nov 20174:38 pmRNSTR-1: notification of major holdings
15th Nov 201710:33 amRNSDirector/PDMR Shareholding - Issue of Warrants
15th Nov 20178:05 amRNSChange of Registered Office, Co. Secretary & TVR
15th Nov 20178:01 amRNSBoard changes effective
15th Nov 20177:00 amRNSUpdate on Suspension, CVA, Placing
14th Nov 20177:00 amRNSDirector/PDMR Shareholding
13th Nov 201711:06 amRNSResult of General Meeting
27th Oct 20177:00 amRNSConsolidation of share capital & GM Notice
26th Oct 20177:00 amRNSSuspension update & proposed share consolidation
25th Oct 20174:42 pmRNSTotal Number of CVA Capitalisation Shares
24th Oct 20171:08 pmRNSResult of CVA and General Meeting
5th Oct 20177:00 amRNSProposed CVA, Placing and Board Changes update
3rd Oct 20175:01 pmRNSProposed CVA, Placing and proposed Board Changes
28th Sep 20177:00 amRNSInterim results for six months ended 30 June 2017
11th Sep 20175:39 pmRNSUpdate re suspension
31st Aug 20179:40 amRNSUpdate re suspension: Administrators appointed
23rd Aug 20172:56 pmRNSUpdate re suspension
20th Jul 20179:19 amRNSLoan Note Conversion, Issue of Warrants & Equity
18th Jul 20177:30 amRNSSuspension - Kin Group plc
18th Jul 20177:30 amRNSStatement re. Suspension
7th Jul 20173:15 pmRNSTR-1: Notification of major interest in shares
3rd Jul 20177:00 amRNSConversion of loan notes, issue of warrants &TVR
20th Jun 20177:00 amRNSNon Regulatory - new contract - NHS Trust
14th Jun 20177:00 amRNSGrant of Options
13th Jun 20177:00 amRNSConvertible Loan Notes update
30th May 20177:00 amRNSConversion of Loan Notes, Issue of Warrants & TVR
15th May 20177:00 amRNSConvertible Loan Note Facility
5th May 201712:16 pmRNSResult of AGM, Change of Name and TVRs
11th Apr 20173:06 pmRNSPosting of Annual Report and Notice of AGM
11th Apr 20177:00 amRNSNon Regulatory - Customer renewal
5th Apr 20171:27 pmRNSPublication of Annual Report & Accounts
4th Apr 20177:00 amRNSProposed Change of Name
3rd Apr 20177:00 amRNSFinal Results for the year ended 31 December 2016
22nd Feb 20177:00 amRNSNon Regulatory - New client contract win
16th Feb 20177:00 amRNSNon Regulatory - Results of Case Study
13th Feb 20177:00 amRNSChange of Registered Office
25th Jan 20177:00 amRNSCompletion of Placing
19th Jan 20171:30 pmRNSRestoration - Fitbug Holdings plc
19th Jan 201712:57 pmRNSTrading Update
18th Jan 20173:23 pmRNSSuspension - Fitbug Holdings Plc
18th Jan 20177:00 amRNSNew customer win covering 14,000 employees
16th Jan 20177:00 amRNSChange of Adviser
13th Dec 20167:00 amRNSCorporate Wellness Partnership
8th Nov 20167:00 amRNSDirectorate Change
21st Sep 201611:15 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.